How Is Sterile Filtration Technology Transforming Vietnam’s Pharmaceutical Industry?

In recent years, Vietnam’s pharmaceutical and vaccine industry has entered a period of rapid growth with significant investments in:

• EU-GMP manufacturing facilities
• Biopharmaceutical production lines
• Next-generation vaccine technologies

Alongside this expansion comes increasingly stringent requirements for:

• Contamination control throughout the manufacturing process
• Absolute sterility of final products
• Higher operational efficiency and reduced product loss
• Compliance with international standards such as GMP-WHO, EU GMP Annex 1, and FDA regulations

In this context, sterile filtration technology is no longer just a technical step — it has become the “heart” of modern biopharmaceutical manufacturing systems.

Today, manufacturers are prioritizing investments in:
✅ High-performance membrane filtration systems
✅ Automated integrity testing technologies
✅ Flexible single-use solutions
✅ International-standard validation processes

These technologies help companies:
✔️ Improve product quality
✔️ Reduce cross-contamination risks
✔️ Increase manufacturing stability
✔️ Meet global GMP inspection requirements

Filterfine & Entegris Technical Seminar – A Comprehensive View of Vietnam’s Filtration Industry in 2026

On May 7, 2026, at POLYVAC (Center for Research and Production of Vaccines and Medical Biologicals), Filterfine Vietnam and Entegris successfully organized an advanced technical seminar focused on pharmaceutical and vaccine filtration solutions.

The event gathered over 50 experts, engineers, QC managers, and QA specialists from leading pharmaceutical and biotech organizations, including:

• Polyvac
• Vabiotech
• Genfarma
• Pharbaco
• Phenikaa
• Merap Group
• Medion
• Vetvaco
• and many others

The seminar featured dynamic discussions and technical sessions centered around the latest trends in filtration and BioProcessing technologies.

Key Highlights from the Seminar

✅ Pharmsteri™ PES Filtration Systems

Entegris specialists introduced the next-generation Pharmsteri™ PES membrane filtration technology with outstanding capabilities:

• Higher filtration flow rates
• Reduced protein binding
• Extended membrane lifespan
• Optimized performance for complex biological fluids

Key product lines included:

• GHF Series: Ideal for buffers and chemical filtration
• GHC Series: Optimized for high-load cell culture media applications

✅ Integrity Testing

Participants received hands-on technical training on:

• Pre-use and post-use integrity testing procedures
• Membrane integrity data analysis
• Factors affecting integrity testing results
• Troubleshooting and corrective actions

This process plays a critical role in contamination control according to ASTM F838 requirements.

✅ Filter Validation & ATAC

Industry experts shared practical guidance on:

• Filtration system validation
• Validation documentation development
• Material compatibility assessment
• Reducing GMP qualification timelines

✅ Single-use BioProcessing

The Aramus™ Single-use solution attracted strong interest due to its ability to:

• Reduce downtime
• Eliminate complex CIP/SIP processes
• Minimize cross-contamination risks
• Increase manufacturing flexibility

✅ New GMP Annex 1 Trends

The seminar also covered the latest updates regarding:

• Contamination Control Strategy (CCS)
• Cleanroom environmental monitoring
• Sterility risk management
• Mandatory integrity testing requirements

These updates provided valuable insights for pharmaceutical manufacturers planning future GMP system upgrades.

3 Major Technology Trends in Pharmaceutical Filtration

1. Increasing Adoption of Integrity Testing

Integrity Testing is becoming mandatory in all modern sterile filtration processes.

Previously, many manufacturers focused mainly on filtration efficiency without fully verifying membrane performance before and after use.

Today, international GMP standards require:
✅ Pre-use integrity testing
✅ Post-use integrity testing
✅ Full validation data storage
✅ Automated data traceability

Common testing methods include:

• Bubble Point Test
• Diffusion Test
• Pressure Hold Test

Benefits include:
✔️ Reduced contamination risks
✔️ Improved batch quality assurance
✔️ Greater confidence during GMP inspections
✔️ Lower product recall risks

2. Transition Toward Single-use Technologies

Single-use systems are becoming an essential trend in the global BioPharma industry, and Vietnam is rapidly following this direction.

Modern biopharmaceutical facilities prioritize solutions that are:

• Flexible
• Scalable
• Efficient
• Low-risk for contamination

Why Single-use Is Growing Rapidly

✅ No complex CIP/SIP requirements
✅ Reduced operational costs
✅ Faster product changeover
✅ Ideal for small and multi-product batches

Particularly in:

• Vaccine manufacturing
• Monoclonal antibodies
• Biotherapeutics
• Cell therapy production

Single-use systems help manufacturers:
✔️ Accelerate commercialization
✔️ Reduce CAPEX investment
✔️ Optimize facility space
✔️ Respond quickly to market demands

3. Optimization of Next-generation PES Membrane Performance

PES membrane filtration has become the preferred choice for biopharmaceutical applications due to its excellent compatibility with sensitive biological fluids.

Next-generation PES membranes such as Pharmsteri™ provide:
✔️ Higher filtration throughput
✔️ Reduced fouling and clogging
✔️ Lower protein adsorption
✔️ Longer system lifespan
✔️ Stable long-term filtration performance

These advantages are especially critical for:

• Cell culture media
• Protein-containing solutions
• Biologic vaccines
• Final filtration applications

By optimizing membrane performance, manufacturers can:
🚀 Reduce production time
🚀 Improve product recovery efficiency
🚀 Lower replacement costs
🚀 Enhance GMP process stability

Vietnam Is Entering a Rapid BioPharma Growth Phase

The strong expansion of Vietnam’s pharmaceutical and biotech sectors is creating major opportunities for sterile filtration technologies.

Current investment priorities include:

• Next-generation vaccines
• Biopharmaceuticals
• EU-GMP facilities
• Advanced sterile manufacturing systems
• Single-use technologies
• Validation and contamination control systems

Many companies are actively investing in:
✅ Production line upgrades
✅ GMP standardization
✅ Automated testing systems
✅ International filtration technologies

This is a critical period for manufacturers to:
🚀 Increase global competitiveness
🚀 Meet export requirements
🚀 Expand international markets
🚀 Optimize long-term manufacturing efficiency

Filterfine Vietnam – Supporting the Future of Pharmaceutical Manufacturing

As an authorized partner of Entegris, Filterfine Vietnam provides not only advanced filtration products but also comprehensive technical support for pharmaceutical manufacturers.

We offer:
✅ Complete sterile filtration solutions
✅ Pharmsteri™ PES membrane systems
✅ Single-use BioProcessing solutions
✅ Validation & ATAC consulting
✅ Advanced Integrity Testing training
✅ GMP manufacturing optimization support
✅ GMP Annex 1 upgrade consulting

With experienced technical specialists and direct support from Entegris, Filterfine Vietnam is committed to helping manufacturers:
✔️ Reduce contamination risks
✔️ Improve operational efficiency
✔️ Optimize manufacturing costs
✔️ Achieve international GMP compliance
✔️ Strengthen global competitiveness

We believe advanced filtration technology will become a critical foundation for the sustainable growth of Vietnam’s pharmaceutical industry in the modern BioPharma era.

📩 Contact Filterfine Vietnam today for expert consultation on sterile filtration solutions tailored to your manufacturing system.